Compare NVS & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVS | UBS |
|---|---|---|
| Founded | 1895 | 1862 |
| Country | Switzerland | Switzerland |
| Employees | 75267 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.5B | 154.6B |
| IPO Year | N/A | 2014 |
| Metric | NVS | UBS |
|---|---|---|
| Price | $148.64 | $46.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $144.00 | $60.30 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.16% | 1.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.30 | $7.40 |
| Revenue Next Year | $5.27 | $2.83 |
| P/E Ratio | $23.13 | ★ $17.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $112.34 | $30.39 |
| 52 Week High | $170.46 | $49.36 |
| Indicator | NVS | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 55.57 |
| Support Level | $145.30 | $46.32 |
| Resistance Level | $152.55 | $48.43 |
| Average True Range (ATR) | 1.93 | 0.75 |
| MACD | -0.25 | -0.15 |
| Stochastic Oscillator | 59.99 | 45.21 |
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.